Anteris Technologies Global Corp. (NASDAQ:AVR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Anteris Technologies Global Corp. (NASDAQ:AVR) has been given an average recommendation of “Moderate Buy” by the five analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $16.00.

Several analysts have recently commented on the stock. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Wells Fargo & Company began coverage on shares of Anteris Technologies Global in a report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 target price for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, March 27th. Barclays lifted their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th.

Anteris Technologies Global Stock Performance

AVR stock opened at $9.34 on Tuesday. The firm has a market cap of $909.16 million, a PE ratio of -4.19 and a beta of 1.77. The firm’s 50 day moving average price is $6.90 and its 200-day moving average price is $5.92. Anteris Technologies Global has a one year low of $2.85 and a one year high of $10.14.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The firm had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. During the same period in the previous year, the firm posted ($0.61) EPS. Equities research analysts predict that Anteris Technologies Global will post -1.14 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Susan Elizabeth Knight bought 11,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was purchased at an average price of $9.29 per share, for a total transaction of $102,190.00. Following the acquisition, the director owned 11,000 shares of the company’s stock, valued at approximately $102,190. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 4.50% of the company’s stock.

Institutional Trading of Anteris Technologies Global

Several institutional investors have recently added to or reduced their stakes in the stock. L1 Capital Pty Ltd increased its holdings in Anteris Technologies Global by 143.2% in the 3rd quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after purchasing an additional 4,026,136 shares during the last quarter. ADAR1 Capital Management LLC increased its holdings in Anteris Technologies Global by 205.9% in the 1st quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock valued at $21,030,000 after purchasing an additional 2,550,355 shares during the last quarter. Perceptive Advisors LLC increased its holdings in Anteris Technologies Global by 104.4% in the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock valued at $19,011,000 after purchasing an additional 1,750,000 shares during the last quarter. Nantahala Capital Management LLC grew its stake in shares of Anteris Technologies Global by 31.9% in the fourth quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock worth $12,629,000 after acquiring an additional 612,244 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Anteris Technologies Global by 32.7% in the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock worth $6,379,000 after acquiring an additional 349,299 shares in the last quarter.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.